#latebreaker2
ASTRAL-1 study of #Sofosbuvir #Velpatasvir FDC for 12 Weeks in GT 1, 2, 4, 5, 6 #HCV w&w/o cirrhosis #LiverLeader #latebreaker2 #liver15
December 3, 2024 at 12:44 PM